#NIFTY50 #NIFTYBANK #NAVNETEDUL
FrontPage is India's Stock Market Social Network
Join 50,000+ Traders and Investors
NAVNETEDUL
84.2
-3.4 (-3.88%)
Updated 03:28 18/01 IST
NAVNETEDUL Buy or Sell - FrontPage Forums
0 Users have submitted 0 trade ideas of Rs. 0 for NAVNETEDUL
Disclaimer0% Bullish
0% Bearish
NAVNETEDUL Buy or Sell - Brokerage Reports
No. of reports in last year
5
No. of analysts
2
Average Consensus Forecast
97.4
Consensus Potential
8.65%
NAVNETEDUL Ratings
Long term NAVNETEDUL rating by FrontPage users
- ★★
- ★★
- ★★
- ★★
- ★★
5/5 (2 Ratings)
Find answers to all your questions on live NAVNETEDUL message board: Is NAVNETEDUL buy or sell? Should I buy NAVNETEDUL shares? Why are NAVNETEDUL shares falling? Should I invest in NAVNETEDUL stock?
- Home
- NAVNETEDUL Forum
NAVNETEDUL Share Price Discussion
G
Reputation: 16,746 • Dec 17, 2020 5:39 AM
GameChangers in NAVNETEDULTrade entered: Buy NAVNETEDUL @87.85 Target@100...
Like
Reply
N
Reputation: 10,022 • Nov 18, 2020 7:48 AM
Accumulate Navneet Education; target of Rs 93: Prabhudas Lilladher
Prabhudas Lilladher recommended accumulate rating on Navneet Education with a target price of Rs 93 in its research report dated November 11, 2020.
Prabhudas Lilladher recommended accumulate rating on Navneet Education with a target price of Rs 93 in its research report dated November 11, 2020.
Moneycontrol
Like
Reply
N
Reputation: 10,022 • Nov 17, 2020 6:28 AM
Hold Natco Pharma; target of Rs 970: ICICI Direct
ICICI Direct recommended hold rating on Natco Pharma with a target price of Rs 970 in its research report dated November 13, 2020.
ICICI Direct recommended hold rating on Natco Pharma with a target price of Rs 970 in its research report dated November 13, 2020.
Moneycontrol
Like
Reply
R
Reputation: 2,252 • Nov 12, 2020 5:00 AM
Prabhudas Lilladher target on NAVNETEDUL
Date: 11-Nov-20
Broker: Prabhudas Lilladher
Price @ Call: 78.14
Target: 93
Potential: 0.19%
Recommendation: ACCUMULATE
Like
Reply
N
Reputation: 10,022 • Nov 12, 2020 11:13 AM
Natco Pharma Q2 net profit up 73% to Rs 204 crore
The company had posted a net profit of Rs 117.7 crore for the corresponding period of the previous fiscal, Natco Pharma said in a BSE filing.
The company had posted a net profit of Rs 117.7 crore for the corresponding period of the previous fiscal, Natco Pharma said in a BSE filing.
Moneycontrol
Like
Reply
N
Reputation: 10,022 • Sep 21, 2020 9:13 AM
Natco Pharma aims to diversify product portfolio in domestic market
New Delhi, Sep 21 Natco Pharma plans to diversify its product portfolio in the domestic market as it aims to make up for a drop in business of some..
New Delhi, Sep 21 Natco Pharma plans to diversify its product portfolio in the domestic market as it aims to make up for a drop in business of some..
Moneycontrol
Like
Reply
N
Reputation: 10,022 • Sep 18, 2020 10:38 AM
Buy Natco Pharma: target of Rs 954: ICICI Securities
ICICI Securities is bullish on Natco Pharma recommended buy rating on the stock with a target price of Rs 954 in its research report dated September 18, 2020.
ICICI Securities is bullish on Natco Pharma recommended buy rating on the stock with a target price of Rs 954 in its research report dated September 18, 2020.
Moneycontrol
Like
Reply
N
Reputation: 10,022 • Sep 14, 2020 7:26 AM
Stock market update: Nifty Media index rises 2%; Dish TV climbs 5%
The index was trading 2.21 per cent up at 1665.95.
The index was trading 2.21 per cent up at 1665.95.
The Economic Times
Like
Reply
N
Reputation: 10,022 • Aug 24, 2020 7:41 AM
Stock market update: Media stocks gain; Zee Entertainment jumps 5%
The Nifty Media index was trading 1.05 per cent up at 1592.45.
The Nifty Media index was trading 1.05 per cent up at 1592.45.
The Economic Times
Like
Reply
N
Reputation: 10,022 • Aug 16, 2020 2:48 AM
Hold Natco Pharma; target of Rs 881: Geojit
Geojit recommended accumulate rating on Natco Pharma with a target price of Rs 881 in its research report dated August 14, 2020.
Geojit recommended accumulate rating on Natco Pharma with a target price of Rs 881 in its research report dated August 14, 2020.
Moneycontrol
Like
Reply
N
Reputation: 10,022 • Aug 16, 2020 2:48 AM
Accumulate Navneet Education; target of Rs 94: Prabhudas Lilladher
Prabhudas Lilladher recommended accumulate rating on Navneet Education with a target price of Rs 94 in its research report dated August 13, 2020.
Prabhudas Lilladher recommended accumulate rating on Navneet Education with a target price of Rs 94 in its research report dated August 13, 2020.
Moneycontrol
Like
Reply
N
Reputation: 10,022 • Aug 14, 2020 6:03 AM
Buy Natco Pharma; target of Rs 950: ICICI Direct
ICICI Direct is bullish on Natco Pharma has recommended buy rating on the stock with a target price of Rs 950 in its research report dated August 13, 2020.
ICICI Direct is bullish on Natco Pharma has recommended buy rating on the stock with a target price of Rs 950 in its research report dated August 13, 2020.
Moneycontrol
Like
Reply
N
Reputation: 10,022 • Aug 12, 2020 10:28 AM
Natco Pharma Q1 net profit declines 14.5% to Rs 122 crore
The company had posted a net profit of Rs 142.8 crore for the corresponding period of the previous fiscal, Natco Pharma said in a BSE filing.
The company had posted a net profit of Rs 142.8 crore for the corresponding period of the previous fiscal, Natco Pharma said in a BSE filing.
Moneycontrol
Like
Reply
N
Reputation: 10,022 • Aug 10, 2020 5:06 AM
Share market update: Media shares advance; DB Corp jumps 5%
The Nifty Media index was trading 0.36 per cent up at 1340.8.
The Nifty Media index was trading 0.36 per cent up at 1340.8.
The Economic Times
Like
Reply
N
Reputation: 10,022 • Aug 3, 2020 1:03 AM
Hot Stocks | Natco Pharma, Godrej Properties two buy calls for short-term
The actual weakness would start only if Nifty sustains below 10,870, till then, one should continue with a stock-specific positive bias.
The actual weakness would start only if Nifty sustains below 10,870, till then, one should continue with a stock-specific positive bias.
Moneycontrol
Like
Reply
N
Reputation: 10,022 • Jul 27, 2020 12:48 PM
Hot Stocks | Natco Pharma, IRB Infra two buy calls for the short term
As we step into the monthly expiry week, our eyes would be on a few crucial levels. On the upside, 11,250 is the level to watch out for, whereas, 11,050 has now become key support.
As we step into the monthly expiry week, our eyes would be on a few crucial levels. On the upside, 11,250 is the level to watch out for, whereas, 11,050 has now become key support.
Moneycontrol
Like
Reply
N
Reputation: 10,022 • Jul 9, 2020 7:13 AM
Top stocks to bet on: ICICI Bank, Biocon, Rallis India can return 15-20% in near term
On the upside, the Nifty needs to sustain 10,800 for the uptrend to continue towards 11,100 and then possibly 11,350.
On the upside, the Nifty needs to sustain 10,800 for the uptrend to continue towards 11,100 and then possibly 11,350.
Moneycontrol
Like
Reply
N
Reputation: 10,022 • Jul 7, 2020 12:43 PM
Hot Stocks | Natco Pharma, NCC, Century Textiles three short-term buy calls
On the weekly chart, Nifty has formed a bullish higher top higher bottom pattern. A similar pattern is also observed in the Midcap and Smallcap indices, indicating broad-based rally in the markets.
On the weekly chart, Nifty has formed a bullish higher top higher bottom pattern. A similar pattern is also observed in the Midcap and Smallcap indices, indicating broad-based rally in the markets.
Moneycontrol
Like
Reply
N
Reputation: 10,022 • Jun 19, 2020 5:18 AM
Buy Natco Pharma; target of Rs 740: ICICI Direct
ICICI Direct is bullish on Natco Pharma has recommended buy rating on the stock with a target price of Rs 740 in its research report dated June 19, 2020.
ICICI Direct is bullish on Natco Pharma has recommended buy rating on the stock with a target price of Rs 740 in its research report dated June 19, 2020.
Moneycontrol
Like
Reply
N
Reputation: 10,022 • Jun 19, 2020 3:48 AM
Buy Navneet Education; target of Rs 95: ICICI Direct
ICICI Direct is bullish on Navneet Education has recommended buy rating on the stock with a target price of Rs 95 in its research report dated June 15, 2020.
ICICI Direct is bullish on Navneet Education has recommended buy rating on the stock with a target price of Rs 95 in its research report dated June 15, 2020.
Moneycontrol
Like
Reply
N
Reputation: 10,022 • Jun 19, 2020 3:33 AM
Hold Navneet Education; target of Rs 89: Prabhudas Lilladher
Prabhudas Lilladher recommended Hold rating on Navneet Education with a target price of Rs 89 in its research report dated June 18, 2020.
Prabhudas Lilladher recommended Hold rating on Navneet Education with a target price of Rs 89 in its research report dated June 18, 2020.
Moneycontrol
Like
Reply
R
Reputation: 2,252 • Jun 19, 2020 3:00 AM
Prabhudas Lilladher target on NAVNETEDUL
Date: 18-Jun-20
Broker: Prabhudas Lilladher
Price @ Call: 80.01
Target: 89
Recommendation: ACCUMULATE
Like
Reply
N
Reputation: 10,022 • Jun 18, 2020 3:58 AM
Natco Pharma Standalone March 2020 Net Sales at Rs 420.10 crore, up 0.91% Y-o-Y
Moneycontrol
Like
Reply
N
Reputation: 10,022 • Jun 18, 2020 3:43 AM
Natco Pharma Consolidated March 2020 Net Sales at Rs 454.80 crore, down 0.2% Y-o-Y
Moneycontrol
Like
Reply
N
Reputation: 10,022 • Jun 17, 2020 8:03 AM
Natco Pharma's Q4 net profit falls 22%; shares drop 3%
Consolidated revenue declined marginally by 0.2 percent YoY to Rs 454.8 crore in Q4FY20 against Rs 455.7 crore in Q4FY19.
Consolidated revenue declined marginally by 0.2 percent YoY to Rs 454.8 crore in Q4FY20 against Rs 455.7 crore in Q4FY19.
Moneycontrol
Like
Reply
N
Reputation: 10,022 • May 19, 2020 8:38 AM
Coronavirus pandemic | Natco Pharma donates chloroquine tablets for global trials
The trial will examine whether the anti-malarial drug can protect essential healthcare workers from COVID-19 virus.
The trial will examine whether the anti-malarial drug can protect essential healthcare workers from COVID-19 virus.
Moneycontrol
Like
Reply
N
Reputation: 10,022 • Apr 28, 2020 6:18 AM
Natco Pharma gains on US FDA approval; share up 27% in a month
The share price up 27 percent in last 1-month.
The share price up 27 percent in last 1-month.
Moneycontrol
Like
Reply
R
Reputation: 2,252 • Apr 20, 2020 4:00 AM
Prabhudas Lilladher target on NAVNETEDUL
Date: 19-Apr-20
Broker: Prabhudas Lilladher
Price @ Call: 65.57
Target: 82
Recommendation: BUY
Like
Reply
N
Reputation: 10,022 • Mar 19, 2020 1:23 AM
Stocks in the news: VST Tillers Tractors, Karur Vysya Bank, Vakrangee, NTPC, Emami
VST Tillers Tractors | Karur Vysya Bank | Vakrangee | NTPC | Emami and NLC India are among the stocks that are in the news today.
VST Tillers Tractors | Karur Vysya Bank | Vakrangee | NTPC | Emami and NLC India are among the stocks that are in the news today.
Moneycontrol
Like
Reply
N
Reputation: 10,022 • Mar 18, 2020 1:48 AM
Trade Setup for Thursday: Top 15 things to know before Opening Bell
Key support level for Nifty is placed at 8208.05, followed by 7947.3. If the index moves up, key resistance levels to watch out for are 8928.55 and 9388.3.
Key support level for Nifty is placed at 8208.05, followed by 7947.3. If the index moves up, key resistance levels to watch out for are 8928.55 and 9388.3.
Moneycontrol
Like
Reply
N
Reputation: 10,022 • Feb 13, 2020 2:48 AM
Natco Pharma Consolidated December 2019 Net Sales at Rs 482.20 crore, down 13.38% Y-o-Y
Moneycontrol
Like
Reply
N
Reputation: 10,022 • Feb 12, 2020 12:13 PM
Natco Pharma Q3 net profit declines 34% to Rs 104.4cr
Consolidated total income stood at Rs 513 crore for the quarter under consideration. It was Rs 580 crore for the same period a year ago.
Consolidated total income stood at Rs 513 crore for the quarter under consideration. It was Rs 580 crore for the same period a year ago.
Moneycontrol
Like
Reply
R
Reputation: 2,252 • Feb 4, 2020 7:00 AM
ICICIdirect.com target on NAVNETEDUL
Date: 04-Feb-20
Broker: ICICIdirect.com
Price @ Call: 91.5
Target: 115
Recommendation: BUY
Like
Reply
R
Reputation: 2,252 • Feb 3, 2020 6:00 AM
Prabhudas Lilladher target on NAVNETEDUL
Date: 03-Feb-20
Broker: Prabhudas Lilladher
Price @ Call: 92.75
Target: 108
Recommendation: BUY
Like
Reply
N
Reputation: 10,022 • Feb 1, 2020 6:18 AM
Budget 2020: Rs 99,300 crore set aside for education sector; Navneet Education, NIIT in focus
Government to source more ECB & FDI for the education sector, says FM Nirmala Sitharaman.
Government to source more ECB & FDI for the education sector, says FM Nirmala Sitharaman.
Moneycontrol
Like
Reply
A
Reputation: 19,243 • Dec 30, 2019 6:13 AM
Crisil has given A+ credit rating for commercial paper.
Like
Reply
R
Reputation: 2,252 • Nov 15, 2019 5:00 AM
Prabhudas Lilladher target on NAVNETEDUL
Date: 14-Nov-19
Broker: Prabhudas Lilladher
Price @ Call: 98.67
Target: 142
Recommendation: BUY
Like
Reply
N
Reputation: 10,022 • Oct 1, 2019 4:23 AM
Natco Pharma gets EIR from USFDA for Hyderabad facility
In a BSE filing, Natco Pharma announced "successful closure of inspection" with the receipt of an establishment inspection report (EIR) from the US Food and Drug Administration (USFDA) for the inspection conducted at its active pharmaceutical ingredient (API) facility in Mekaguda Village, near Hyderabad, India.
In a BSE filing, Natco Pharma announced "successful closure of inspection" with the receipt of an establishment inspection report (EIR) from the US Food and Drug Administration (USFDA) for the inspection conducted at its active pharmaceutical ingredient (API) facility in Mekaguda Village, near Hyderabad, India.
Moneycontrol
Like
Reply
N
Reputation: 10,022 • Aug 13, 2019 9:18 AM
Buy Navneet Education; target of Rs 130: ICICI Direct
ICICI Direct is bullish on Navneet Education has recommended buy rating on the stock with a target price of Rs 130 in its research report dated August 12, 2019.
ICICI Direct is bullish on Navneet Education has recommended buy rating on the stock with a target price of Rs 130 in its research report dated August 12, 2019.
moneycontrol.com
Like
Reply
N
Reputation: 10,022 • Aug 13, 2019 6:43 AM
Hold Natco Pharma; target of Rs 595: ICICI Direct
ICICI Direct recommended hold rating on Natco Pharma with a target price of Rs 595 in its research report dated August 12, 2019.
ICICI Direct recommended hold rating on Natco Pharma with a target price of Rs 595 in its research report dated August 12, 2019.
moneycontrol.com
Like
Reply
N
Reputation: 10,022 • Aug 12, 2019 9:08 AM
Buy Navneet Education; target of Rs 134: Prabhudas Lilladher
Prabhudas Lilladher is bullish on Navneet Education has recommended buy rating on the stock with a target price of Rs 134 in its research report date August 09, 2019.
Prabhudas Lilladher is bullish on Navneet Education has recommended buy rating on the stock with a target price of Rs 134 in its research report date August 09, 2019.
moneycontrol.com
Like
Reply
N
Reputation: 10,022 • Aug 9, 2019 9:13 AM
Natco Pharma Consolidated June 2019 Net Sales at Rs 492.30 crore, down 8.6% Y-o-Y
moneycontrol.com
Like
Reply
N
Reputation: 10,022 • Aug 9, 2019 9:13 AM
Natco Pharma Standalone June 2019 Net Sales at Rs 464.70 crore, down 9.89% Y-o-Y
moneycontrol.com
Like
Reply
N
Reputation: 10,022 • Aug 5, 2019 7:18 AM
Natco Pharma gets EIR from USFDA for Kothur facility
The receipt of EIR from the United States Food and Drug Administration (USFDA) indicates the successful closure of inspection of the company’s drug formulations facility in Kothur, Natco Pharma said in a BSE filing.
The receipt of EIR from the United States Food and Drug Administration (USFDA) indicates the successful closure of inspection of the company’s drug formulations facility in Kothur, Natco Pharma said in a BSE filing.
moneycontrol.com
Like
Reply
N
Reputation: 10,022 • Jul 29, 2019 2:13 AM
Stocks in the news: ICICI Bank, Cadila Health, Mahindra Life, Vedanta, Uflex, Granules, NHPC
Maruti Suzuki | Allahabad Bank | Future Lifestyle Fashions | ICICI Bank | Power Mech Projects | Manpasand Beverages and Usha Martin are stocks which are in news today.
Maruti Suzuki | Allahabad Bank | Future Lifestyle Fashions | ICICI Bank | Power Mech Projects | Manpasand Beverages and Usha Martin are stocks which are in news today.
www.moneycontrol.com
Like
Reply
N
Reputation: 10,022 • Jul 29, 2019 1:18 AM
Stocks in the news: ICICI Bank, Cadila Health, Mahindra Life, Vedanta, Uflex, Granules India
Maruti Suzuki | Allahabad Bank | Future Lifestyle Fashions | ICICI Bank | Power Mech Projects | Manpasand Beverages and Usha Martin are stocks which are in news today.
Maruti Suzuki | Allahabad Bank | Future Lifestyle Fashions | ICICI Bank | Power Mech Projects | Manpasand Beverages and Usha Martin are stocks which are in news today.
www.moneycontrol.com
Like
Reply
N
Reputation: 10,022 • Jul 18, 2019 7:33 AM
Navneet Publication Q1 PAT seen up 16.4% YoY to Rs. 147 cr: ICICI Direct
Like
Reply
N
Reputation: 10,022 • Jul 15, 2019 4:33 AM
Natco Pharma says USFDA inspection at Chennai facility ends with zero observations
Like
Reply
Join FrontPage
FrontPage is India's favorite stock discussions community
Join 50,000 Indian traders and discuss trades, strategies, news & views on any stock.
- keyboard_arrow_down
NAVNETEDUL Share Price - Technicals
- NewsBotNov 18, 2020 7:48 AMAccumulate Navneet Education; target of Rs 93: Prabhudas LilladherMoneycontrolNewsBotAug 16, 2020 2:48 AMAccumulate Navneet Education; target of Rs 94: Prabhudas LilladherMoneycontrolNewsBotJun 19, 2020 3:48 AMBuy Navneet Education; target of Rs 95: ICICI DirectMoneycontrolNewsBotJun 19, 2020 3:33 AMHold Navneet Education; target of Rs 89: Prabhudas LilladherMoneycontrolNewsBotJun 18, 2020 3:58 AMNatco Pharma Standalone March 2020 Net Sales at Rs 420.10 crore, up 0.91% Y-o-YMoneycontrolNewsBotJun 18, 2020 3:43 AMNatco Pharma Consolidated March 2020 Net Sales at Rs 454.80 crore, down 0.2% Y-o-YMoneycontrolNewsBotApr 28, 2020 6:18 AMNatco Pharma gains on US FDA approval; share up 27% in a monthMoneycontrolNewsBotMar 19, 2020 1:23 AMStocks in the news: VST Tillers Tractors, Karur Vysya Bank, Vakrangee, NTPC, EmamiMoneycontrolNewsBotMar 18, 2020 1:48 AMTrade Setup for Thursday: Top 15 things to know before Opening BellMoneycontrolNewsBotFeb 13, 2020 2:48 AMNatco Pharma Consolidated December 2019 Net Sales at Rs 482.20 crore, down 13.38% Y-o-YMoneycontrol
SOURCE: Data from D'Market via Quandl. Intraday data delayed 15 minutes.
DISCLAIMER: Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and FrontPage will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein.